香港飛台北 相關
廣告上個月有 超過 10 萬 名用戶曾瀏覽 tw.trip.com
在 Trip.com 尋找優惠機票並計劃完美的旅程。 TripGenie 提供客製化的輕鬆旅遊體驗。
Join The World's Largest Travel Subscription Program and Take Advantage of our Discounts. Choose Your Flight, Go to the Payment Page, Add Prime and the Discount Will Be Applied
Book with Confidence on OneTravel®. Save up to $15 on our Booking Fees. Book Cheap Flights by Comparing 500+ Airlines. Price Match Promise
搜尋結果
香港國際機場 台北 - 機票搜尋
Powered by
2024年5月15日 · Major R&D Pipeline. (As of May 15, 2024) Major R&D Pipeline. Neurology. Oncology. Global Health. Gastrointestinal Disorders. Other. :Development progress from January 2024 onwards ：Development progress from April 2023 onwards.
2021年6月30日 · Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) announced today that its Hong Kong subsidiary Eisai (Hong Kong) Co., Ltd. has launched the in-house-discovered and developed orexin receptor antagonist DAYVIGO ® (generic name: lemborexant) for the treatment of adults with insomnia, characterized by difficulties with sleep onset an...
2024年5月15日 · October 13, 2023. Eisai Inc.'s U.S. Headquarters Earns Three Key Building Certifications Efforts Aimed to Help Sustain the Environment, Boost Employee Health & Wellness. March 9, 2023. Warning Against Solicitation, Fraudulent Emails, etc. that Use the Name of Eisai or Related Parties. February 17, 2023.
Welcome to the Eisai Official Corporate Website Eisai Group Worldwide Page
Oral / Injection. Description: Selectively inhibits the AMPA receptor (a glutamate receptor subtype) activation by glutamate. Approved as an adjunctive therapy for partial-onset seizures in over 75 countries including Japan, China and countries in Europe and in Asia. Approved for monotherapy in Japan and China.
Class of shares to be cancelled: Ordinary shares of the Company. Number of shares to be cancelled: All of shares acquired pursuant to 2. above. Cancellation date: November 29, 2024 (planned) (For Reference) Status of treasury shares as of March 31, 2024: Total number of issued shares (excluding treasury shares): 287,035,548 shares.
Halaven (anticancer agent) Jyseleca (janus kinase inhibitor) Elental (branched-chain amino acid preparation) *. Goofice (chronic constipation treatment) *. Fycompa (antiepileptic agent) Movicol (chronic constipation treatment) *. Pariet (proton-pump inhibitor) *. Aricept (Alzheimer's disease / Dementia with Lewy bodies treatment) Consumer ...
